Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsIfeyinwa Onyiuke, MBBS
Assistant Clinical ProfessorDownloadHi-Res Photo
About
Copy Link
Appointments
Radiology & Biomedical Imaging
Assistant Clinical ProfessorPrimary
Other Departments & Organizations
Education & Training
- MBBS
- University of nigeria (1968)
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Ifeyinwa Onyiuke's published research.
Tamar Taddei, MD
Maxwell Laurans, MD, MBA, FAANS
Michal Rose, MD
Rajni Mehta, MPH
Tassos C. Kyriakides, PhD
Xuchen Zhang, MD, PhD
Publications
2025
Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)
Ioannou G, Taddei T, Planeta B, Huang G, Weiss N, Morgan T, Dominitz J, Abou-Alfa G, Bashir M, Beheshti M, Singal A, Moylan C, Boland R, Buchwalder L, Mehta R, Hoisington K, V. N, Rogal S, Kaplan D, Benhammou J, Su G, McDonald L, Dani G, Dunn D, Chang S, Onyiuke I, Sharma A, Kyriakides T, Su G, Lane A, Baffy G, Lee T, Hunt K, Davitkov P, Hernaez R, Morgan T, Pisegna J, Patel A, Said A, Albanese A, Mannon P, Cheung R, Kaplan D, Patton H, Barnard-Giustini A, Kulkarni P, Jakab S, Azar S, Rau T, Jati A, Hunt K, Kang P, Hanif M, Borghei P, Walsworth M, Swietlik J, Abedin S, Rabe T, Chang S, Khan M, Vahdat N, Rago J, Kumar P, Onyiuke I. Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study). JHEP Reports 2025, 8: 101666. PMID: 41624484, PMCID: PMC12857331, DOI: 10.1016/j.jhepr.2025.101666.Peer-Reviewed Original ResearchCitationsAltmetricConceptsHCC-related mortalityHepatocellular carcinoma screeningAbbreviated MRIVeterans AffairsHepatocellular carcinomaAlpha-fetoproteinDepartment of Veterans AffairsCirrhosis patientsHigh-quality evidenceRandomized Controlled TrialsCurative HCC treatmentVeterans ageHepatocellular carcinoma surveillanceExtracellular gadolinium-based contrast agentsEligible participantsSerum alpha-fetoproteinHepatocellular carcinoma stageAbbreviated MRI protocolHepatocellular carcinoma riskParticipant recruitmentSpecificity of USLife-threatening comorbiditiesSpecialty societiesGadolinium-based contrast agentsT2-weighted sequencesHeterogeneous Tumor Profiles in Hepatocellular Carcinoma: An Example of Late Recurrences With Genetically Distinct Tumors Over a 10-Year Survival
Cao Y, Laurans M, Onyiuke I, Walther Z, Zhang X, Rose M, Taddei T. Heterogeneous Tumor Profiles in Hepatocellular Carcinoma: An Example of Late Recurrences With Genetically Distinct Tumors Over a 10-Year Survival. ACG Case Reports Journal 2025, 12: e01670. DOI: 10.14309/crj.0000000000001670.Peer-Reviewed Original ResearchConceptsHepatocellular carcinomaTumor profilingLate recurrenceNext-generation sequencingRuptured hepatocellular carcinomaMetastasis 3 yearsDistinct tumorsProlonged survivalGenetically distinct tumorsRecurrenceUnique caseTargeted mutationCarcinomaTumorClinical insightsSurvivalPresentationGenetic sequencesPatients